Serum periostin as a novel biomarker and therapeutic target in coronary heart disease
This integrated bioinformatics analysis provided valuable insights into the molecular landscape of CAD, highlighting <i>POSTN</i> as a potential biomarker for diagnosis and prognosis. Future research is needed to validate these findings in clinical settings and explore therapeutic targets within the identified pathways.
Authors
- Zhipeng Deng (ORCID: https://orcid.org/0009-0005-7602-5460)
- Lei Yao (ORCID: https://orcid.org/0009-0003-4773-8029)
- Shu He
- Q. Y. Su (ORCID: https://orcid.org/0000-0003-3007-7298)
- Lu Li (ORCID: https://orcid.org/0000-0003-1643-1684)
- Boxiang Du (ORCID: https://orcid.org/0000-0002-9089-1884)
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-12-02
- DOI
- https://doi.org/10.3389/fcvm.2025.1556634
- Primary Topic
- Cardiac Fibrosis and Remodeling
- Type
- article
- Field-Weighted Citation Impact
- 0.00